Company: LIFD
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001096906-25-001332
Chunk: 81

Company: LFTD PARTNERS INC.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 81
---
 least 50,000 shares traded on each of those 20 consecutive trading days.  As of June 30, 2025, 60,000 shares of Series B Preferred Stock have been converted into a total of 60,000 shares of common stock of the Company, which leaves 40,000 shares of Series B Preferred Stock currently outstanding, convertible into 40,000 shares of common stock of the Company; these are not included in the diluted earnings calculation. As of June 30, 2024, the Company had 40,000 shares of Series B Preferred Stock outstanding convertible into 40,000 shares of common stock; these are not included in the diluted earnings calculation. As of June 30, 2025 and December 31, 2024, the Company has accrued a liability of $4,771 and $1,796, respectively, as dividends payable to holders of the Series B Convertible Preferred Stock. The Company fully intends on paying the annual dividends to the holders of the Series B Convertible Preferred Stock, and as such, the Company has accrued the liability on the Series B Convertible Preferred Stock. During the three and six months ended June 30, 2025 and 2024, no cash dividends were paid to the Series B Convertible Preferred Stock holders. Share-Based Compensation  At the closing of the acquisition of Lifted, 645,000 shares of unregistered common stock of the Company were designated as contingent deferred compensation (the “Deferred Contingent Stock”) to certain persons specified by NWarrender in a schedule delivered by him to the Company at the closing of the Merger (the “Deferred Contingent Stock Recipients”). Now that certain conditions and requirements have been met, starting on February 24, 2023, the Deferred Contingent stock has begun to be issued to certain Deferred Contingent Stock Recipients who have instructed the Company to issue to them their respective, earned Deferred Contingent Stock. There were 142,000 shares of Deferred Contingent Stock, issuable upon instruction by the respective Deferred Contingent Stock Recipients, outstanding as of June 30, 2025; these are included in the June 30, 2025 diluted EPS calculation. There were also 142,000 shares of issuable Deferred Contingent Stock included in the June 30, 2024 diluted EPS calculation.

 F-14Table of Contents

 Options and Warrants As of June 30,